Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 34 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 8 | 2820%/yr | 0%/yr | 1.20.4× | 0% | 180 in 2030−7.3%/yr |
| Decompression & minimally invasive spine |
How the numbers are made · Every state · Compare two markets
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 7 |
| 250−13%/yr |
| −13%/yr |
| 1.00.3× |
| 0% |
| 350 in 2030+5.7%/yr |
| Cervical fusion & disc arthroplasty | 2 | 123−6.5%/yr | −6.5%/yr | 0.50.4× | 0% | 250 in 2030+13%/yr |
| Kyphoplasty & vertebroplasty | 1 | 106−5.5%/yr | −5.5%/yr | 0.50.5× | 0% | 90 in 2030−3.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 89 | 14,7060%/yr | 0%/yr | 61.00.6× | 60% | 15,300 in 2030+0.7%/yr |
| Skin substitutes & wound grafts | 9 | 2,075+17%/yr | +17%/yr | 5.60.4× | 92% | 2,610 in 2030+3.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 39 | 2,542+2.5%/yr | +2.5%/yr | 10.51.1× | 73% | 3,290 in 2030+4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 8 | 925−4.6%/yr | −4.6%/yr | 3.80.7× | 96% | 850 in 2030−1.4%/yr |
| Dialysis access | 7 | 658−16%/yr | −16%/yr | 3.00.6× | 83% | 1,090 in 2030+8.7%/yr |
| Peripheral arterial intervention | 3 | 559−14%/yr | −14%/yr | 2.30.5× | 9% | 460 in 2030−3.1%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 215+4.7%/yr | +4.7%/yr | 0.90.8× | 0% | 60 in 2030−18%/yr |
| Carotid revascularization | 1 | 111−8.3%/yr | −8.3%/yr | 0.50.6× | 0% | 150 in 2030+5.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 11 | 986−2.8%/yr | −2.8%/yr | 4.50.8× | 1% | 970 in 2030−0.2%/yr |
| Cholecystectomy & appendectomy | 9 | 736−6.4%/yr | −6.4%/yr | 3.30.9× | 0% | 870 in 2030+2.8%/yr |
| Colorectal resection | 0 | 182−11%/yr | −11%/yr | 0.80.6× | 0% | 170 in 2030−1.5%/yr |
| Antireflux & hiatal hernia surgery | 1 | 129−1.8%/yr | −1.8%/yr | 0.60.8× | 0% | 130 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 11 | 549−4.5%/yr | −4.5%/yr | 2.40.7× | 2% | 570 in 2030+0.7%/yr |
| BPH procedures | 10 | 453−21%/yr | −21%/yr | 2.00.4× | 7% | 410 in 2030−1.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 5 | 427−0.8%/yr | −0.8%/yr | 2.00.9× | 16% | 400 in 2030−1.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 2 | 167−7.1%/yr | −7.1%/yr | 0.70.4× | 9% | 240 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 2 | 212−18%/yr | −18%/yr | 0.90.2× | 72% | 280 in 2030+4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 18 | 1,102−4.4%/yr | −4.4%/yr | 5.10.8× | 61% | 1,100 in 20300%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 26 | 3,176+18%/yr | +18%/yr | 13.60.7× | 77% | 6,050 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 11 | 618−2.3%/yr | −2.3%/yr | 2.80.7× | 0% | 670 in 2030+1.3%/yr |
| EP ablation | 8 | 559+9.8%/yr | +9.8%/yr | 2.00.7× | 0% | 1,040 in 2030+11%/yr |
| LAA occlusion & loop recorders | 5 | 431+11%/yr | +11%/yr | 1.60.6× | 2% | 1,040 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 18 | 1,021−9%/yr | −9%/yr | 3.60.8× | 0% | 1,030 in 2030+0.2%/yr |
| Structural heart (TAVR, TEER) | 9 | 207+20%/yr | +20%/yr | 0.80.5× | 0% | 260 in 2030+4%/yr |
| Mechanical circulatory support | 2 | 123−0.2%/yr | −0.2%/yr | 0.51.2× | 0% | 80 in 2030−6.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 34 | 9,620−3.6%/yr | −3.6%/yr | 41.10.9× | 92% | 10,700 in 2030+1.8%/yr |
| Vitreoretinal surgery | 8 | 477−2%/yr | −2%/yr | 2.10.8× | 54% | 440 in 2030−1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 87 | 16,821−4.2%/yr | −4.2%/yr | 75.90.7× | 40% | 17,500 in 2030+0.7%/yr |
| ERCP & endoscopic ultrasound | 8 | 365−15%/yr | −15%/yr | 1.60.5× | 0% | 390 in 2030+1.1%/yr |
| Bronchoscopy & lung nodule | 4 | 210+8.1%/yr | +8.1%/yr | 0.90.4× | 0% | 570 in 2030+18%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.